Medication info
Entitelmi Plus Tablet 40/12.5 milligrams

Entitelmi Plus Tablet 40/12.5 milligrams

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Korea Sintex Pharmaceutical Co., Ltd.
Appearance
White or whitish, oval-shaped tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201906944 · Approved 2019.09.30 · Insurance code 623005960

Summary

Main use
Treatment of essential hypertension not adequately controlled with telmisartan alone
Who takes it
Adults · Children
Adult dose
ADULTS For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this fixed-dose combination, it is recommended that the dose of each component be individually adjusted. When clinically appropriate, a direct switch from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg plus hydrochlorothiazide 12.5mg as separate products or with the combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. This medicine should not be administered to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild to moderate hepatic impairment. The daily dose should not exceed 40/12.5mg. This medicine should not be administered to patients with severe hepatic impairment (see Precautions for Use, section 2). Thiazide diuretics should be used with caution in patients with impaired liver function. Elderly patients No dosage adjustment is necessary.
Child dose
The safety and efficacy of this medicine have not been established in children under 18 years of age.

Ingredients

Manufacturer
Korea Sintex Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not adequately controlled with telmisartan alone

  • Essential hypertension
View approved original text

In patients with essential hypertension whose blood pressure cannot be adequately controlled with telmisartan alone, adding this medication can effectively manage blood pressure. This medication improves hypertension treatment and helps prevent cardiovascular complications.

How to take

Adult dose

ADULTS For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this fixed-dose combination, it is recommended that the dose of each component be individually adjusted. When clinically appropriate, a direct switch from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg plus hydrochlorothiazide 12.5mg as separate products or with the combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. This medicine should not be administered to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild to moderate hepatic impairment. The daily dose should not exceed 40/12.5mg. This medicine should not be administered to patients with severe hepatic impairment (see Precautions for Use, section 2). Thiazide diuretics should be used with caution in patients with impaired liver function. Elderly patients No dosage adjustment is necessary.

Child dose

The safety and efficacy of this medicine have not been established in children under 18 years of age.

Precautions

This medication can pose serious risks to the fetus during pregnancy, particularly in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. This medication should not be used in individuals with allergies to the active ingredients or excipients, hypersensitivity to sulfonamide drugs, pregnant or breastfeeding women, those with biliary obstruction or cholestatic disorders, severe liver or kidney impairment, acute glomerulonephritis or anuria, certain electrolyte imbalances, or those combining it with specific drugs in diabetic or moderate to severe kidney impairment patients. Elderly patients, those with hyperkalemia, liver impairment, valvular heart disease, ischemic heart disease, or cerebrovascular disorders should use this medication with caution, and due to increased risk of skin cancer, sun exposure should be limited while regularly reviewing skin conditions. This medication can cause various side effects including hypotension, dizziness, orthostatic hypotension, electrolyte imbalances, liver function abnormalities, skin rash, myalgia, dyspnea, among others, so immediate consultation with a healthcare provider is necessary if abnormal symptoms occur. Particularly, this medication may affect fluid and electrolyte balance, requiring regular blood tests and kidney function tests; interactions with other drugs necessitate caution during co-administration. It should not be used during pregnancy and should be avoided while breastfeeding. In case of overdose, symptoms such as hypotension, electrolyte imbalances, and dehydration may occur, requiring immediate medical treatment. Safety and efficacy have not been established in children under 18 years of age, and usage in elderly patients should be cautious to avoid excessive blood pressure reduction. This medication should be kept out of reach of children, and transferring it to another container is not recommended.

Side effects

  • Bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disturbances
Show 114 more
  • dizziness
  • syncope
  • paresthesia
  • visual impairment
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory distress
  • pneumonia
  • pulmonary edema
  • diarrhea
  • dry mouth
  • bloating
  • abdominal pain
  • constipation
  • dyspepsia
  • vomiting
  • gastritis
  • liver dysfunction
  • liver disease
  • vascular edema
  • erythema
  • pruritus
  • rash
  • sweating
  • urticaria
  • back pain
  • muscle cramps
  • myalgia
  • arthralgia
  • limb pain
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • increased blood uric acid
  • increased blood creatinine
  • increased blood creatine phosphokinase
  • increased liver enzymes
  • upper respiratory tract infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • bradycardia
  • cough
  • interstitial lung disease
  • dry mouth
  • abdominal discomfort
  • eczema
  • drug rash
  • toxic skin rash
  • bone pain
  • renal dysfunction
  • weakness
  • increased blood creatinine
  • decreased hemoglobin
  • sialadenitis
  • non-melanoma skin cancer
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • hypersensitivity
  • aplastic anemia
  • decreased appetite
  • hypomagnesemia
  • hyperglycemia
  • hypercalcemia
  • hypochloremic alkalosis
  • necrotizing vasculitis
  • acute respiratory distress syndrome
  • nausea
  • pancreatitis
  • jaundice
  • biliary stasis
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • systemic lupus erythematosus
  • acute renal failure
  • diabetes
  • weakness
  • fever
  • nausea
  • gastrointestinal bleeding
  • esophagitis
  • headache
  • tremor
  • facial flushing
  • malaise
  • fatigue
  • weight loss
  • proteinuria
  • itching
  • myalgia
  • floating sensation
  • lip and hand tremor
  • sensory hypersensitivity
  • vision impairment
  • hypoglycemia
  • intestinal vascular edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature to preserve its effectiveness and safety over time.

Appearance and packaging

Appearance

White or whitish, oval-shaped tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.